PRESENTATIONS FROM OCULAR MELANOMA CONFERENCES

Day 1 Video

Medical Presentations:

• Primary Disease: Intra-Ocular Melanocytic Lesions  (Dr. Ezekiel Weis; 40 minutes)

• Estimation of Metastatic Risk in Uveal Melanoma  (Dr. Hatem Krema; 55 minutes)

• Genomic Testing for Uveal Melanoma  (Castle Biosciences' Katherina Alsina, PhD, 15 minutes)

• Uveal Melanoma Prognostic Tumor Test  (Impact Genetics' Jaime Jessen, Certified Genetic Counselor; 10 minutes)

Day 2 Video

Medical Presentations:

• Metastatic Uveal Melanoma  (Dr. Marcus Butler; 45 minutes) 

Presentations by patients are also included in each day's video.

Links to the conference's videos will be posted here when they are available on the internet.

Links to the conference's videos will be posted here when they are available on the internet.

OM Diagnosis, Genetics, Treatment, and Research:

• KIMMTRAK Approved: Now What?  (Dr. Meredith McKean and Dr. Justin Moser; 50 minutes)

• Ocular Melanoma Mets Explained  (Dr. Meredith McKean, Dr. Justin Moser, and Dr. Maureen Sanger; 50 minutes)

• Standards of Care in Uveal Melanoma  (Dr. Peter Hovland, Dr. David Reichstein, and Dr. Amy Schefler; 55 minutes)

• What Is the INSIGHT Ocular Melanoma Patient Registry?  (Dr. Armin Afshar; 35 minutes)

• Your Eye After Treatment  (Dr. David Reichstein; 55 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:  

Link to videotaped conference presentation on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage. 

All videotaped presentations from this conference

Video Recordings of Clinical Research Sessions: Part 1

• Primary Ocular Melanoma 101  (Dr. Carol Shield; 51:25 to 1:27:04)

• Post-Primary Treatment  (Dr. Sara Lally; 1:27:04 to 1:51:21)

• Surveillance and Adjuvant Therapy  (Dr. Rino Seedor; 1:51:21 to 2:10:00)

• Past, Present, and Future of Uveal Melanoma  (Dr. Takami Sato; 2:49:00 to 3:19:40)

Video Recordings of Clinical Research Sessions: Part 2

• Treatments for Metastatic Disease: Liver Directed Therapies  (Order of presenters: Dr. Rani Anne, Dr. Robert Adamo, and Dr. Carin Gonsalves; 0:00 to 1:08:07) 

• Treatments for Metastatic Disease: Immunotherapies  (Marlana Orloff; 1:08:07 to 1:34:52)

• Treatments for Metastatic Disease: Molecular Targeted Therapies  (Dr. Rino Seedor; 1:34:52 to 1:51:57)

• Basic Science Updates  (Dr. Andrew Aplin; 1:51:57 to 2:19:07)

• Closing Remarks  (Dr. Sara Selig; 2:19:07 to 2:25:00)

Video Recording 1:

• Current and Emerging Systemic Treatment Choices for Metastatic Uveal Melanoma  (Dr. Paul Nathan; 30 minutes)

Video Recording 2:

• Novel Treatments of Uveal Melanoma  (Prof. Jonas Nilsson; 20 minutes)

• Liver-Directed Therapies for Metastatic Uveal Melanoma  (Dr. David Eschelman; 20 minutes)

Video Recording 3:

• Australian National Uveal Melanoma Treatment Pathway  (Dr. John McKenzie; 20 minutes)

• Ocular Prostheses  (Ocularist Camille Loyer; 15 minutes)

Video Recording 4:

• A Global Survey on Ruthenium Eye Plaque Practice  (Dr. Lotte Fog; 15 minutes)

• Another Option in the Radiotherapy Toolkit: Gantry-Based Proton Therapy  (Dr. Amanda Deisher; 15 minutes)

• Proton Therapy for Uveal Melanoma  (Dr. Sachin Salvi; 20 minutes)

Video Recording 5:

• Pathology of Uveal Melanoma  (Prof. Penny McKelvie; 20 minutes)

• Transretinal Tumour Biopsy Techniques  (Prof. Heinrich Heimann; 15 minutes)

• Uveal Melanoma Biopsy at the Time of Plaque Brachytherapy  (Dr. Rod O'Day; 15 minutes)

Video Recording 6:

• Genetics and Genomics in Uveal Melanoma  (Dr. Peter Johansson; 15 minutes)

• Proteomics in Uveal Melanoma  (Prof. Sarah Coupland; 15 minutes)

• Liquid Biopsies in Uveal Melanoma  (Dr. Aaron Beasley; 15 minutes)

OM Diagnosis, Genetics, Treatment, and Research:

• Ocular Melanoma Advocacy  (Melanoma Research Foundation's Cassie Beisel; 50 minutes)

• Ocular Melanoma Clinical Trials  (Dr. Richard Carvajal, Dr. Marlana Orloff, Dr. Sapna Patel, and Dr. Sara Selig; 75 minutes)

• Upcoming Ocular Melanoma Treatments  (Dr. Richard Carvajal and Dr. Sara Selig; 35 minutes)

• VISION Registry Update  (Dr. Richard Carvajal and Dr. Sara Selig; 60 minutes)

All videotaped presentations from this conference

OM Diagnosis, Genetics, Treatment, and Research: 

• How My Patients Made Me a Better Ocular Oncologist  (Dr. Bertil Damato; 45 minutes)

• Keynote Presentation: What's New in Uveal Melanoma in 2021  (Dr. Prithvi Mruthyunjaya; 45 minutes)

• Making Drug Development Work For Uncommon Cancers  (Dr. Anthony Tolcher; 45 minutes)

• Navigating a Diagnosis of Metastatic Uveal Melanoma  (Dr. Adil Daud and Dr. Justin Moser; 50 minutes)

• Treatment of Advanced Uveal Melanoma  (Dr. Jose Lutzky; 45 minutes)

• Uveal Melanoma Genetics Explained  (Genetic counselor Jaime Jessen and Dr. Basil Williams; 50 minutes)

• What to Expect After Radiation Treatment for Uveal Melanoma: A Patient's Perspective  (Dr. Armin Afshar and Dr. Timothy Murray; 50 minutes)

• What's New in Uveal Melanoma — NCCN Guidelines' Prognostic Information and Standards of Care  (Dr. David Reichstein, Dr. Amy Schefler, and Dr. Andrew Stacey; 50 minutes) 

• Why Should I Join a Registry? About the INSIGHT Ocular Melanoma Patient Registry  (Dr. Armin Afshar and Dr. Bertil Damato; 45 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:  

Links to videotaped conference presentations on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage. 

All videotaped presentations from this conference

All the meeting's ocular melanoma presentations can be viewed in the following two parts by anyone after free online registration. (Note: Select "not a healthcare professional" to eliminate pre-test process for continuing education credit.)

Part 1:

One-hour video — OM presentations begin at 11:50 mark in the following order:

• Potential Application of Liquid Biopsies for Uveal Melanoma  (Dr. Elin Gray; 6 minutes)

• Uveal Melanoma: Proteomic Biomarkers  (Dr. Vinit Mahajan; 5 minutes)

• Molecular-Guided Clinical Trial Design in Uveal Melanoma  (Dr. J. William Harbour; 7 minutes)

• Panel Discussion  (24 minutes)

View Part 1 as shown above

Part 2:

Two-hour video — In its first hour, OM presentations begin at 14:20 mark in the following order:

• Targeted Treatment of Uveal Melanoma with Viral-Like Drug Conjugates  (Dr. Ivana Kim; 6 minutes)

• Dose Reduction Strategies for Plaque Brachytherapy  (Dr. Miguel Materin; 5 minutes)

• Anti-VEGF vs. Intravitreal Steroids for Prevention of Vision Loss Due to Radiation Retinopathy  (Dr. Daniel Martin; 8 minutes)

• Panel Discussion  (26 minutes)

In its second hour, OM presentations begin at 1:07:10 mark in the following order:

• Drug Toxicities from Cancer Therapies  (Dr. Dan Gombos; 7 minutes)

• Machine Learning in Ocular Melanoma Detection  (Dr. Mandeep Sagoo; 8 minutes)

• AI-Based Histopathologic Tumor Analysis  (Dr. Zelia Correa; 6 minutes)

• Panel Discussion  (21 minutes)

• A Perspective on Unmet Needs in Uveal Melanoma  (Dr. Carol Shields; 10 minutes)

• Activating a Research Network to Tackle a Yet Uncured Disease: COOG2  (Dr. Thomas Aaberg, Jr.; 7 minutes)

• Panel Discussion  (25 minutes)

View Part 2 as shown above